These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19282387)

  • 1. A novel androgen receptor amino terminal region reveals two classes of amino/carboxyl interaction-deficient variants with divergent capacity to activate responsive sites in chromatin.
    Need EF; Scher HI; Peters AA; Moore NL; Cheong A; Ryan CJ; Wittert GA; Marshall VR; Tilley WD; Buchanan G
    Endocrinology; 2009 Jun; 150(6):2674-82. PubMed ID: 19282387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.
    Tan JA; Bai S; Grossman G; Titus MA; Harris Ford O; Pop EA; Smith GJ; Mohler JL; Wilson EM; French FS
    Mol Cell Endocrinol; 2014 Jan; 382(1):302-313. PubMed ID: 24103312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
    Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
    Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction.
    Bai S; He B; Wilson EM
    Mol Cell Biol; 2005 Feb; 25(4):1238-57. PubMed ID: 15684378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells.
    Buchanan G; Need EF; Barrett JM; Bianco-Miotto T; Thompson VC; Butler LM; Marshall VR; Tilley WD; Coetzee GA
    Mol Cell Endocrinol; 2011 Aug; 342(1-2):20-31. PubMed ID: 21664238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif.
    Jin F; Claessens F; Fondell JD
    J Biol Chem; 2012 Jan; 287(2):858-70. PubMed ID: 22102282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells.
    Yang X; Guo Z; Sun F; Li W; Alfano A; Shimelis H; Chen M; Brodie AMH; Chen H; Xiao Z; Veenstra TD; Qiu Y
    J Biol Chem; 2011 Oct; 286(41):36152-36160. PubMed ID: 21878636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.
    Minges JT; Su S; Grossman G; Blackwelder AJ; Pop EA; Mohler JL; Wilson EM
    J Biol Chem; 2013 Jan; 288(3):1939-52. PubMed ID: 23172223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain in transcriptional activity by primate-specific coevolution of melanoma antigen-A11 and its interaction site in androgen receptor.
    Liu Q; Su S; Blackwelder AJ; Minges JT; Wilson EM
    J Biol Chem; 2011 Aug; 286(34):29951-63. PubMed ID: 21730049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
    Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
    Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling human androgen receptor mutations reveals treatment effects in a mouse model of prostate cancer.
    O'Mahony OA; Steinkamp MP; Albertelli MA; Brogley M; Rehman H; Robins DM
    Mol Cancer Res; 2008 Nov; 6(11):1691-701. PubMed ID: 19010817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual function of an amino-terminal amphipatic helix in androgen receptor-mediated transactivation through specific and nonspecific response elements.
    Callewaert L; Verrijdt G; Christiaens V; Haelens A; Claessens F
    J Biol Chem; 2003 Mar; 278(10):8212-8. PubMed ID: 12509416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer.
    Han G; Foster BA; Mistry S; Buchanan G; Harris JM; Tilley WD; Greenberg NM
    J Biol Chem; 2001 Apr; 276(14):11204-13. PubMed ID: 11063747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.
    Haelens A; Tanner T; Denayer S; Callewaert L; Claessens F
    Cancer Res; 2007 May; 67(9):4514-23. PubMed ID: 17483368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity.
    He B; Gampe RT; Hnat AT; Faggart JL; Minges JT; French FS; Wilson EM
    J Biol Chem; 2006 Mar; 281(10):6648-63. PubMed ID: 16365032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer.
    Han D; Gao S; Valencia K; Owiredu J; Han W; de Waal E; Macoska JA; Cai C
    Oncotarget; 2017 Jan; 8(4):6796-6808. PubMed ID: 28036278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.
    Guo Z; Yang X; Sun F; Jiang R; Linn DE; Chen H; Chen H; Kong X; Melamed J; Tepper CG; Kung HJ; Brodie AM; Edwards J; Qiu Y
    Cancer Res; 2009 Mar; 69(6):2305-13. PubMed ID: 19244107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collocation of androgen receptor gene mutations in prostate cancer.
    Buchanan G; Greenberg NM; Scher HI; Harris JM; Marshall VR; Tilley WD
    Clin Cancer Res; 2001 May; 7(5):1273-81. PubMed ID: 11350894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer.
    Liu Y; Majumder S; McCall W; Sartor CI; Mohler JL; Gregory CW; Earp HS; Whang YE
    Cancer Res; 2005 Apr; 65(8):3404-9. PubMed ID: 15833875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin.
    Li J; Fu J; Toumazou C; Yoon HG; Wong J
    Mol Endocrinol; 2006 Apr; 20(4):776-85. PubMed ID: 16373397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.